Clinical Versus Home Introduction of Milk in Children with Non-IgE-mediated Cow's Milk Allergy
ENIGMA
Evaluation of the Outcome of Clinical or Home Introduction of Milk in Children with Non-IgE-mediated Cow's Milk Allergy (ENIGMA Trial)
Sponsor study identifier
interventional
120
1 country
1
Study Start
October 9, 2023
Actual (reported)Primary Completion
June 1, 2026
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Study Completion
June 1, 2026
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
There are a lot of parents who believe that their child may not tolerate cow's milk because they develop symptoms such as redness of the skin or they may vomit. It is not always easy to find out if these infants should indeed avoid drinking cow's milk or that the symptoms are caused by something else, for instance because they have a viral illness. The goal of the investigators is to find out if cow's milk should be introduced in the hospital or if it can also be advised to perform the introduction at home to determine if an infant can drink cow's milk without developing symptoms. Half of the participants will drink cow's milk in the hospital. This test is performed on two days. On one of the days cow's milk will be offered. On the other day a look-alike substance is offered. The other half of the participants will drink cow's milk at home by starting to drink a little bit of milk and in a few steps drink a normal bottle of cow's milk. The main question is whether both tests can be used to find out if an infant can drink cow's milk without developing symptoms.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
June 1, 2026
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
February 24, 2023
Actual (reported)March 27, 2023
Actual (reported)October 9, 2023
Actual (reported)June 1, 2026
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
June 1, 2026
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Number of participants with a positive or negative test
Positive (intolerant) or negative (tolerant) outcome of the introduction test
Determined 1 week after start of the test
Regular milk consumption
Determined 6 weeks after completion of the test
Percentage and type of reported symptoms
Determined 6 weeks after completion of the test
Healthcare utilisation during the study period
Determined 6 weeks after completion of the test
Introduction of cow's milk by means of an adjusted double blind placebo controlled challenge test
Introduction of cow's milk by means of a standardized schedule
clinical introduction of cow's milk
clinical introduction of placebo
Martini Hospital
Groningen, Netherlands
Kamps, MD, PhD
Martini Ziekenhuis Groningen
First Submitted
February 24, 2023
First Posted
March 27, 2023
Study Start
October 9, 2023
Actual (reported)Primary Completion
June 1, 2026
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Oral Immunotherapy for Children With Cow's Milk Allergy
home introduction of cow's milk
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Contact the study team to confirm eligibility.
Study Completion
June 1, 2026
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Last Updated
November 25, 2024
Record last verified: 2024-11
Study protocol and data will be shared upon request
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: